informed consent

Latisse

We want to make sure you fully understand your treatment. 
Below outlines the benefits, expectations, and risks with 
Latisse (bimatoprost ophthalmic solution) 0.03% treatment.

BenefitsRisksInstructions

Benefits

What are the benefits of Latisse?

Bimatoprost ophthalmic solution 0.03% (Latisse) has been proven to make lashes longer, fuller, and darker. It works by extending the growth phase of your eyelashes.

The development of longer, thicker, and fuller eyelashes is gradual and was noted after 2-4 months of treatment in clinical studies. When discontinued, lashes gradually returned to their baseline.

Number (%) of subjects with at least a 1-grade increase from baseline in Global Eyelash Assessment (Primary Efficacy Endpoint – Week 16)

latisse-table

Risks

What are the side effects of Latisse?

The most frequently reported adverse reactions were eye itching, redness, and irritation; dry eye symptoms; and eyelid skin darkening and redness. These reactions occurred in less than 4% of patients.

Darkening of eyelid skin caused by Latisse will increase as long as the product is used. This may be reversible after stopping Latisse.

Latisse can stimulate hair growth in other areas where it is applied. You should avoid applying the medication onto adjacent skin.

Iris darkening may occur and is likely permanent. In a pooled safety analysis of patients using Latisse for eyelash growth, iris pigmentation occurred in 2 of 680 patients (0.3%). In glaucoma patients who apply the medication in the eye, iris pigmentation occurred in 0.9-1.5% of patients.

Patients with green-brown, yellow-brown, and blue/gray-brown eyes appear to be at highest risk. Patients with homogeneously blue, gray, green, or brown eyes are seldom affected. It does not appear to affect nevi or freckles on the iris.

Periorbital fat atrophy was reported in 1 of 680 Latisse patients (0.15%) in a pooled safety analysis. This caused deepening/hollowing of the eyelid crease. This side effect occurs more commonly in glaucoma patients who apply the medication in the eye.

You should not use Latisse if:

  • You have intraocular inflammation (e.g. uveitis).
  • You have known risk factors for macular edema (such as an absent or torn lens of the eye).
  • If you are allergic to Latisse or to benzalkonium.
  • It should be used with caution in pregnant and lactating patients.

You should stop Latisse if:

  • You develop a new ocular condition (e.g. trauma or infection).
  • You experience a sudden decrease in visual acuity.
  • You have ocular surgery.
  • You develop any intolerable eye symptoms.

Soft contact lens wearers:

The Latisse contains benzalkonium chloride, which may cause discoloration of soft contact lenses. Contact lenses should be removed prior to application of solution and may be reinserted 15 minutes following its administration.

Instructions

STEP 1

Before applying

Before applying Latisse, wash your face and remove your makeup and contact lenses, and apply all other facial skincare products that you want to use.

STEP 2

Prepare the applicator

First remove the Latisse applicator from the tray. Then hold the applicator sideways and place a single drop of Latisse solution on the area closest to the tip (but not on the tip) of the Latisse applicator.

STEP 3

Apply to skin using Latisse applicator

Gently run the applicator along the skin at the base of your upper eyelashes (where the eyelash meets the skin). Start at the inner part of your lash line and move towards the outer part. DO NOT APPLY in your eye or to the lower lid.

STEP 4

Blot excess Latisse off face

Blot any excess Latisse solution that went beyond the eyelid with a tissue or absorbent cloth.

STEP 5

Dispose of Latisse applicator

Dispose of your Latisse applicator after one use. Repeat steps for opposite eyelid using a new sterile applicator. This will help reduce chances of potential contamination from your first eyelid to your second.

Still thinking about it? 💭

Sign up for our newsletter to get $10 off your Apostrophe medication. 🤑